CareDx Announces Completion of Sale of Lab Products Business to Eurobio Scientific

CareDx completed the sale of its Lab Products business to Eurobio Scientific for $171.2 million in cash, following receipt of Swedish regulatory clearance. The divested business includes IVD PCR and NGS-based kits for HLA typing and transplant monitoring assays sold outside North America. CEO John Hanna said the transaction sharpens CareDx's focus on its core U.S. Precision Medicine Testing Services and Patient and Digital Solutions, while simplifying the operating model and supporting disciplined capital allocation.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.